Ulrik Niels Lassen

Ulrik Niels Lassen

Clinical Professor

Member of:

  • Clinical Oncology


  1. 2008
  2. Published

    Phase II study of a 3-day schedule with topotecan and cisplatin in patients with previously untreated small cell lung cancer and extensive disease

    Sorensen, M., Lassen, Ulrik Niels, Jensen, P. B., Østerlind, K., Jeppesen, N., Jensen, B. B., Mellemgaard, A., Rytter, C. & Langer, Seppo W., Aug 2008, In: Journal of Thoracic Oncology. 3, 8, p. 902-6 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial

    Sorensen, M., Lassen, Ulrik Niels, Palshof, T., Jensen, B. B., Johansen, J., Jensen, P. B. & Langer, Seppo W., May 2008, In: Lung Cancer. 60, 2, p. 252-8 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Phase II study of a 3-day schedule with topotecan and cisplatin in patients with previously untreated small cell lung cancer and extensive disease

    Sorensen, M., Lassen, Ulrik Niels, Jensen, P. B., Østerlind, K. E., Jeppesen, N., Jensen, B. B., Mellemgaard, A., Rytter, C. & Langer, Seppo W., 2008, In: Journal of Thoracic Oncology. 3, 8, p. 902-906 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial

    Sorensen, M., Lassen, Ulrik Niels, Palshof, T., Jensen, B. B., Johansen, J., Jensen, P. B. & Langer, S. W., 2008, In: Lung Cancer. 60, 2, p. 252-258 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4952653